Wall Street expects coronavirus relief legislation to repair the economy and lift equity assets. Here’s a look at the incoming political reality. Read More

One of our experts reflected on his missed gains of the past year and was reminded that it's tough to beat Wall Street at its own game. Read More

Our system of checks and balances that grants enormous rights to the states has been a friend to marijuana. That friendship keeps getting stronger. Read More

More than $20 billion was raised in SPAC offerings last year. With additional deals on the way in 2021, here's how to get your share of the action. Read More

The pandemic-restrained economic recovery is not-too-hot, not-too-cold, striking a balance that’s “just right” for stocks. Read More

Home prices are sharply rising, in large part because of the coronavirus pandemic. Here’s why that’s good news for the broader stock market. Read More

Trading on headline news can result in huge losses, as this unusual tale involving a misinterpreted tweet from Elon Musk illustrates. Read More

The recovery continues in the new year but the data are mixed. Can stocks stay on track amid this good news/bad news scenario? Read More

The Democratic takeover of the U.S. Senate is setting up a huge “profit catalyst” for the marijuana industry. Here’s how to cash in. Read More

America stands on the cusp of an historic change in federal marijuana laws. At the same time, the pandemic is fueling a surge in pot sales. Read More